On the other hand, mimicking in vivo environment during in vitro investigations in CLL and mantle cell lymphoma cells also showed Mcl-1, Bcl-XL, and survivin as primary determinants of ibrutinib and venetoclax resistance (41). This evidence concerns the gene BCL2L1 and mantle cell lymphoma.